04 Jun 2026
ZS2 Completes First Commercial-Scale North American MgO Cement Production Line
ZS2 develops sustainable, resilient Magnesium Oxide cement building materials that deliver a superior, carbon-negative alternative to traditional building methods.Â
Since we last wrote, there have been several significant developments, accelerating ZS2’s growth trajectory:
ZS2 has installed and begun commissioning its Phase 1 board line, marking a critical transition from lab-scale formulation to pilot-scale manufacturing. This gives the company the ability to produce magnesium cement boards using North American feedstocks and controlled, proprietary systems.
The Company successfully delivered Phase 1 of its Joint Development Agreement with a major US building materials company, with Phase 2 now in its final stage. The next major step under this collaboration is a proposed $17 million USD board plant expansion to support commercialization.
ZS2's focus on asset resilience is gaining traction within the insurance sector. The Company was added to Aviva Canada's Specialist Partner Network for loss prevention and accepted into the MaRS Adaptech Accelerator, which is backed by Definity Insurance.
To support ZS2's ongoing scale-up, the Company is advancing its Series A round following a $2.27 million equity raise in the fall of 2025. The Company also continues to leverage non-dilutive funding from organizations like Emissions Reduction Alberta, the National Research Council, and Prairies Economic Development Canada.
Please contact Mitchell Hauser or Tony Coretto for further information or to arrange a meeting with Scott Jenkins, ZS2's CEO.